Manganese-based MRI contrast agent RVP-001
Term · Oncology and biomedicine · MLC-T-ONC-015000
A contrast agent formulation based on the paramagnetic ion Mn2+, stabilized by the chelator PyC3A, that can potentially be used as a contrast enhancer during magnetic resonance imaging (MRI). Upon administration, manganese-based contrast agent RVP-001 may enhance the visualization of blood vessels, organs and tumors upon MRI.
| Identifier | MLC-T-ONC-015000 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | Mn-PyC3A; MnPyC3A |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-015000",
"term": "Manganese-based MRI contrast agent RVP-001",
"field": "Oncology and biomedicine",
"definition": "A contrast agent formulation based on the paramagnetic ion Mn2+, stabilized by the chelator PyC3A, that can potentially be used as a contrast enhancer during magnetic resonance imaging (MRI). Upon administration, manganese-based contrast agent RVP-001 may enhance the visualization of blood vessels, organs and tumors upon MRI.",
"synonyms": [
"Mn-PyC3A",
"MnPyC3A"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/manganese-based-mri-contrast-agent-rvp-001/"
}
Record 10,610 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.